awareness, Pharma consulting: 医療用医薬品のコンサルティング

Hunting for Cancer Neoantigens : What is the best approach?

Important insights into neoantigen-based immunotherapies and which developers are leading in this growing area.

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

A Tale Of Two Pipelines

Immuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results. It is time to re-evaluate how the sector should be pursuing innovation in cancer and how it can be smarter in its use of resources—financial investment, talent, bandwidth, patients and data.

Breast Cancer Clinical Landscape and Recent Trends Whitepaper

Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

US FDA Approval Of Lynparza For Pancreatic Cancer Opens Door For PFS Endpoint In Disease

AstraZeneca's PARP inhibitor Lynparza becomes first US FDA-approved drug for pancreatic cancer based on progression-free survival endpoint, providing regulatory precedent for other sponsors to use that development approach; all other pancreatic cancer drugs had been approved based on an overall survival benefit.

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Seven Talking Points At ASH 2019

The tireless pace of change in hemato-oncology was showcased in Orlando.

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

How Sustainable Is England's Cancer Drugs Fund?

The Cancer Drugs Fund has improved access to oncology drugs, but if it is to remain fit for purpose it will need to evolve.

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Accord Strikes Thiotepa Deal With Adienne

Accord Healthcare has secured commercial rights to Adienne’s novel lyophilized formulation of thiotepa in Europe, extending its portfolio of cancer treatments.

Medtech Insight: 世界の医療機器・医療技術の最新情報

Laboratory For Advanced Medicine Appoints New CEO, Prepares To Scale Liquid Biopsy Pipeline

With a new CEO at its helm, Laboratory for Advanced Medicine is preparing to take on the cancer-diagnostics market. Former AncestryDNA executive Kenneth Chahine has joined the company as it plans to drive global commercialization of its artificial intelligence liquid biopsy pipeline.